Zhao Qinxian, Cheng Zhigang, Han Zhiyu, Liu Fangyi, Yu Xiaoling, Tan Xianliang, Han Bin, Dou Jianping, Yu Jie, Liang Ping
People's Liberation Army General Hospital, Beijing, China.
Central People's Hospital of Zhanjiang, Zhanjiang, China.
Front Oncol. 2021 May 11;11:638165. doi: 10.3389/fonc.2021.638165. eCollection 2021.
To compare the therapeutic outcomes between open surgical resection (OSR) and percutaneous microwave ablation (PMWA) for colorectal liver metastasis (CRLM) ≤3 cm.
In this retrospective study, 200 consecutive patients with 306 CRLMs were reviewed. Overall survival (OS), disease-free survival (DFS), local tumour progression (LTP), intrahepatic distant recurrence, and extrahepatic metastasis were analysed to compare the therapeutic efficacy. Cox proportional hazards regression analysis was used to identify the prognostic factors for OS and DFS. Major complications and postoperative hospital stay were also assessed.
The 1-, 3-, and 5-year OS rates were 91.6%, 64.1%, and 46.3%, respectively, in the PMWA group and 89.7%, 62.4% and 44.7%, respectively, in the OSR group (P=0.839). The 1-, 3-, and 5-year DFS rates were 61.9%, 44.8%, and 41.3%, respectively, in the PMWA group and 58.1%, 24.4%, and 18.3%, respectively, in the OSR group (P =0.066). The two groups had comparable 5-year cumulative rates of intrahepatic distant recurrence (P=0.627) and extrahepatic metastasis (P=0.884). The 5-year cumulative LTP rate was lower in the OSR group than in the PMWA group (P=0.023). The rate of major complications was higher in the OSR group than in the PMWA group (P =0.025), and the length of hospital stay after treatment was shorter in the PMWA group (P<0.001).
There were no significant differences in OS or DFS between the two groups. PMWA was associated with increased LTP, fewer postoperative days and fewer major complications.
比较开放性手术切除(OSR)与经皮微波消融(PMWA)治疗直径≤3 cm的结直肠癌肝转移(CRLM)的疗效。
在这项回顾性研究中,对200例连续患者的306处CRLM进行了评估。分析总生存期(OS)、无病生存期(DFS)、局部肿瘤进展(LTP)、肝内远处复发和肝外转移情况,以比较治疗效果。采用Cox比例风险回归分析确定OS和DFS的预后因素。还评估了主要并发症和术后住院时间。
PMWA组1年、3年和5年的OS率分别为91.6%、64.1%和46.3%,OSR组分别为89.7%、62.4%和44.7%(P = 0.839)。PMWA组1年、3年和5年的DFS率分别为61.9%、44.8%和41.3%,OSR组分别为58.1%、24.4%和18.3%(P = 0.066)。两组的5年肝内远处复发累积率(P = 0.627)和肝外转移累积率(P = 0.884)相当。OSR组的5年累积LTP率低于PMWA组(P = 0.023)。OSR组的主要并发症发生率高于PMWA组(P = 0.025),PMWA组治疗后的住院时间更短(P < 0.001)。
两组的OS或DFS无显著差异。PMWA与LTP增加、术后天数减少和主要并发症减少相关。